Suppr超能文献

醋酸盐血液透析不会增加血液透析患者心律失常的发生率。

Acetate hemodialysis does not increase the frequency of arrhythmia in hemodialysis patients.

作者信息

Kayatas M, Ertürk A, Muderrisoglu H, Korkmaz M E, Ozdemir F N

机构信息

Department of Nephrology, Baskent University School of Medicine, Ankara, Turkey.

出版信息

Artif Organs. 1998 Sep;22(9):781-4. doi: 10.1046/j.1525-1594.1998.06163.x.

Abstract

Arrhythmia is one of the most important causes of mortality in patients on hemodialysis and may develop due to cardiovascular diseases or fluid-electrolyte or acid-base abnormalities. Previous studies have shown that acetate hemodialysis (AHD) increased the frequency of arrhythmia. To evaluate the frequency and the causes of arrhythmias during AHD, we studied 33 randomly selected patients (25 male and 8 female, mean age of 45+/-18 years) who were under AHD (4 h, 3 times/week, mean duration of HD of 38+/-29 months) with the same Cuprophan membranes. All patients underwent a detailed echocardiographic evaluation during the interdialytic period. Twenty-four hours of Holter monitoring was performed starting from the onset of HD. Twelve lead electrocardiography (ECG) was obtained, and venous and arterial blood samples were drawn for serum electrolytes, pH, and arterial blood gas measurements before and after HD. Serum magnesium and potassium levels dropped after AHD (from 2.3+/-0.5 to 1.9+/-0.3 mEq/L and from 5+/-0.7 to 3.4 +/-0.4 mEq/L respectively, p < 0.001); on the other hand serum pH, bicarbonate, sodium, and calcium levels were normalized. Electrocardiographic evaluation revealed significant lengthening of the QTc interval (from 433+/-42 to 464+/-43 ms, p < 0.001), which was thought to be related to the decrease in serum magnesium and potassium levels. The frequencies of ventricular premature contractions (VPCs) were not different during AHD and the interdialytic period (8+/-9.1 to 6.5+/-11 contractions/h, p > 0.05). This was also true for supraventricular premature contractions (SVPCs) and supraventricular tachycardia (SVT). Nonsustained ventricular tachycardia was observed in 2 patients during HD and in 1 patient in the interdialytic period. No relation was established between the echocardiographic findings and the frequency of arrhythmia. In our ambulatory electrocardiographic study, the frequencies of VPCs and SVPCs observed during the interdialytic period were only positively correlated with age (r=0.54, p=0.013 and r=0.50, p=0.010, respectively). No relation was found between the frequency of arrhythmia and the gender of the patients; duration of HD; etiology of kidney disease; or serum Na, K, Ca, iCa, Mg, bicarbonate, or pH levels (p > 0.05). In conclusion, the application of AHD does not increase the frequency of arrhythmia in HD patients as had been shown in previous studies.

摘要

心律失常是血液透析患者最重要的死亡原因之一,可能由心血管疾病或水电解质及酸碱平衡异常引起。既往研究表明,醋酸盐血液透析(AHD)会增加心律失常的发生率。为评估AHD期间心律失常的发生率及原因,我们对33例随机选取的患者(25例男性,8例女性,平均年龄45±18岁)进行了研究,这些患者使用相同的铜仿膜进行AHD(4小时,每周3次,平均血液透析时间38±29个月)。所有患者在透析间期均接受了详细的超声心动图评估。从血液透析开始进行24小时动态心电图监测。采集12导联心电图(ECG),并在血液透析前后采集静脉和动脉血样本,用于检测血清电解质、pH值和动脉血气。AHD后血清镁和钾水平下降(分别从2.3±0.5降至1.9±0.3 mEq/L和从5±0.7降至3.4±0.4 mEq/L,p<0.001);另一方面,血清pH值、碳酸氢盐、钠和钙水平恢复正常。心电图评估显示QTc间期显著延长(从433±42延长至464±43 ms,p<0.001),这被认为与血清镁和钾水平降低有关。AHD期间室性早搏(VPCs)的发生率与透析间期无差异(8±9.1次/小时至6.5±11次/小时,p>0.05)。室上性早搏(SVPCs)和室上性心动过速(SVT)的情况也是如此。血液透析期间2例患者出现非持续性室性心动过速,透析间期1例患者出现。超声心动图检查结果与心律失常发生率之间未发现关联。在我们的动态心电图研究中,透析间期观察到的VPCs和SVPCs发生率仅与年龄呈正相关(r=0.54,p=0.013和r=0.50,p=0.010)。未发现心律失常发生率与患者性别、血液透析时间、肾脏疾病病因或血清钠、钾、钙、离子钙、镁、碳酸氢盐或pH值水平之间存在关联(p>0.05)。总之,与既往研究结果不同,AHD的应用并未增加血液透析患者心律失常的发生率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验